Sarcoma committee Journal Article


Authors: Eisenberg, B. L.; Alektiar, K.; Ballo, M.; DeLaney, T. F.; Ettinger, D.; Harmon, D.; Harris, J.; Joyce, M.; Kraybill, W. G.; Leider, S.; Lucas, D.; Petersen, I.; Pollock, P. E.; Pritchard, D.; Schwartz, H. S.; Yasko, A. W.; Pisters, P. W. T.; Patel, S. R.; Watson, J.
Article Title: Sarcoma committee
Keywords: platelet derived growth factor; vasculotropin; cancer chemotherapy; cancer surgery; unclassified drug; clinical trial; cancer risk; multimodality cancer therapy; cancer adjuvant therapy; cancer radiotherapy; research design; methodology; cancer grading; organization and management; platelet derived growth factor receptor; angiogenesis; oncology; sarcoma; radiation oncology; limb tumor; forecasting; short survey; high risk population; fibroblast growth factor; professional standard; professional staff committees; retroperitoneal sarcoma; humans; human; priority journal; article; 3 [(4,5 dimethyl 1h pyrrol 2 yl)methylene] 1,3 dihydro 2h indol 2 one; beta fibroblast growth factor
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 51
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2001-01-01
Start Page: 53
End Page: 55
Language: English
DOI: 10.1016/s0360-3016(01)01780-1
PUBMED: 11641015
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 13 November 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kaled M Alektiar
    333 Alektiar